Analystreport

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $50.00 price targ

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com